The Phytoestrogen Genistein Induces Thymic and Immune Changes: A Human Health Concern
Yellayi, Srikanth
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/87122
Description
Title
The Phytoestrogen Genistein Induces Thymic and Immune Changes: A Human Health Concern
Author(s)
Yellayi, Srikanth
Issue Date
2002
Doctoral Committee Chair(s)
Cooke, Paul S.
Department of Study
Veterinary Clinical Medicine
Discipline
Veterinary Clinical Medicine
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Health Sciences, Immunology
Language
eng
Abstract
Use of soy-based infant formulas has aroused concern due to potential estrogenic effects of the soy isoflavones genistein and daidzein. Here we show that subcutaneous genistein injections in ovariectomized adult mice produced dose-responsive decreases in thymic weight of up to 80%. Genistein's thymic effects occurred through both estrogen receptor (ER) and non-ER mediated mechanisms, as the genistein effects on thymus were only partially blocked by the estrogen receptor (ER) antagonist ICI 182,780. ERbeta was not necessary for genistein's actions, as it caused similar degree of thymic atrophy in betaERKO and wild-type animals. Genistein decreased thymocyte numbers up to 86% and doubled apoptosis, indicating that the mechanism of the genistein effect on loss of thymocytes is due in part to increased apoptosis. Genistein injection caused decreases in relative percentages of thymic CD4+CD8- and double-positive CD4+CD8+ thymocytes, providing evidence that genistein may affect early thymocyte maturation and the maturation of the CD4+CD8- helper T cell lineage. Decreases in the relative percentages of CD4+CD8- thymocytes were accompanied by decreases in relative percentages of splenic CD4+CD8- cells and a systemic lymphocytopenia. In addition, genistein produced a dose-dependent suppression of humoral and cell-mediated immunity. Genistein injected at 8 mg/kg/day serum genistein levels comparable to those reported in soy-fed human infants, and this dose caused significant thymic and immune changes in mice. Critically, dietary genistein at concentrations which produced genistein levels less than those in soy-fed infants produced marked thymic atrophy. Furthermore, the effects of genistein on the thymus and the immune system were temporary and reversible. These results suggest that serum genistein concentrations found in soy-fed infants may be capable of producing thymic and immune impairments.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
